Influence of potassium dichromate on tracheal secretions in critically ill patients

M Frass, C Dielacher, M Linkesch, C Endler… - Chest, 2005 - Elsevier
Background Stringy, tenacious tracheal secretions may prevent extubation in patients weaned
from the respirator. This prospective, randomized, double-blind, placebo-controlled study …

Efficacy and outcome of rapid access rheumatology consultation: an office-based pilot cohort study

…, R Janetschko, W Kaiser, M Linkesch… - The Journal of …, 2016 - jrheum.org
Objective. Waiting times for first appointments are a major obstacle to timely rheumatology
care. To improve access, a cooperative of office-based rheumatologists established an …

Effect of recombinant interferon-α2C on reticuloendothelial function in patients with thrombocytosis

…, M LINKESCH, W LINKESCH… - Journal of interferon …, 1990 - liebertpub.com
The aim of the study was to investigate the influence of recombinant interferon-α2C (rIFN-α2C)
on the in vivo Fc-dependent phagocytic activity of the reticuloendothelial (RE) system. …

Paclitaxel-containing high-dose chemotherapy in high-risk breast cancer patients

HT Greinix, W Linkesch, M Seifert, E Kubista… - Acta …, 2000 - Taylor & Francis
Despite standard-dose adjuvant chemotherapy, the prognosis for patients with breast
cancer and extensive axillary lymph node involvement at diagnosis is poor. The efficacy of a …

Interferon-alpha-2C and LD ara-C for the treatment of patients with CML: results of the Austrian multicenter phase II study

J Thaler, W Hilbe, U Apfelbeck, W Linkesch, H Sill… - Leukemia research, 1997 - Elsevier
Small pilot studies of patients with CML have reported on encouraging response rates after
treatment with interferon-alpha (IFNα) in combination with low-dose cytosine arabinoside (LD …

First annual report of the Austrian CML registry.

…, J Thaler, S Burgstaller, W Linkesch… - Wiener Klinische …, 2010 - search.ebscohost.com
The Austrian chronic myeloid leukemia (CML) registry monitors individual disease courses,
treatments applied, clinical outcome, and side effects of CML patients on a nationwide basis …

Erster Jahresbericht des österreichischen CML-Registers

…, D Wolf, J Thaler, S Burgstaller, W Linkesch… - Wiener klinische …, 2010 - Springer
The Austrian chronic myeloid leukemia (CML) registry monitors individual disease courses,
treatments applied, clinical outcome, and side effects of CML patients on a nationwide basis …

[CITATION][C] Informationen für die Klinik

…, R Reichel, H Bartels, W Linkesch… - Oncology Research …, 1989 - karger.com
Erkrankungen des Halte-und Bewegungs-apparates werden in einer stets alter wer-denden
Gesellschaft immer häufiger fest-gestellt. Bei vielen Skelettschädigungen ist eine …

[PDF][PDF] A clinical study on Homoeopathic Management of Bronchial Asthma considering Boenninghausen's totality of symptoms

K Selvi - 2021 - 103.78.239.181
Chronic obstructive pulmonary disease is an inflammatory, progressive lung disease which
is not completely reversible, and it includes chronic bronchitis and emphysema. Major …

Reversal of multi‐drug resistance in human KB cell lines by structural analogs of verapamil

R Pirker, G Keilhauer, M Raschack… - … journal of cancer, 1990 - Wiley Online Library
Several structural analogs of verapamil were studied for their ability to reverse multi‐drug
resistance (MDR) in human KB cell lines. D595, D792 and verapamil completely reversed …